Particle.news

Cochrane Review Finds Intermittent Fasting Offers No Weight-Loss Edge

A new Cochrane analysis of 22 randomized trials finds fasting delivers no clinically meaningful advantage over standard dieting.

Overview

  • Across nearly 2,000 overweight or obese adults, intermittent fasting produced little to no difference in weight loss versus calorie‑focused dietary advice or no intervention.
  • Average losses on fasting plans were about 3% of body weight within 12 months, below the roughly 5% threshold typically considered clinically meaningful.
  • Some protocols, including alternate‑day fasting, showed small additional reductions in individual studies, but the differences did not reach clinical significance.
  • Most trials were short, had methodological shortcomings and were conducted largely in White adults from high‑income countries, limiting long‑term confidence and generalisability.
  • Review authors recommend case‑by‑case clinical guidance and call for longer, more diverse trials that track metabolic outcomes, lean mass changes and participant satisfaction.